Eurofins DiscoverX

Eurofins DiscoverX is a leading provider of innovative cell-based assays and services for drug discovery and development, based in Fremont, California. We empower scientists with trusted solutions to accelerate research and drug discovery programs with confidence. Our comprehensive portfolio includes recombinant GPCR proteins, active cell lines, and ready-to-use assays, supporting applications from initial screening to QC lot release. As the products company of Eurofins Discovery, we’re part of the Eurofins BioPharma global network, contributing to the discovery and development of life-saving therapeutics. We develop and manufacture cutting edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release, pharmacotrafficking, and many other applications.

Eurofins DiscoverX serves a global community of researchers and pharmaceutical companies, providing the tools and expertise needed to navigate complex drug discovery challenges. We specialize in supporting a wide range of target families, including GPCRs, kinases, epigenetics, and ion channels. Our commitment to quality and innovation ensures reliable and reproducible results, accelerating the path to new therapies.

What sets Eurofins DiscoverX apart is our integrated approach, combining cutting-edge technology with deep scientific expertise. We offer custom assay development services, alongside our extensive catalog of validated products. Founded in 2000, we’ve built a strong reputation for delivering exceptional value and supporting breakthrough discoveries. With 118 employees across three centers of excellence – Fremont, St. Louis, and Poitiers – we’re dedicated to advancing the future of medicine.